← Open Payments lookup

DEBRA COLEMAN: Open Payments

NPI 1376378034 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$450 in 24 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $450

Food & beverage: $450
CompanyPaymentsAmount
Lilly USA, LLC5$78
Novo Nordisk Inc4$73
Sumitomo Pharma America, Inc.2$51
ABBVIE INC.2$36
Xeris Pharmaceuticals, Inc.2$31
Astellas Pharma US Inc1$27
Inspire Medical Systems, Inc.1$24
Lundbeck LLC1$23
Otsuka America Pharmaceutical, Inc.1$21
AstraZeneca Pharmaceuticals LP1$21

Products named: MOUNJARO, GEMTESA, REXULTI, VRAYLAR, Rybelsus, GVOKE HYPOPEN, Veozah, INSPIRE.

Industry payments across IA — which companies pay providers there.